This page shows the latest atacicept news and features for those working in and with pharma, biotech and healthcare.
Meanwhile, Merck suffered a setback in its mid-stage pipeline recently after its systemic lupus erythematosus (SLE) candidate atacicept failed to meet its objectives in a clinical trial, although it did
Atacicept is unique in that it is being developed solely for the treatment of lupus. ... Lupus nephritis trials have largely been unsuccessful, therefore it is hoped that, with the change in patient population, atacicept will show some efficacy in these
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
No results were found
We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences...